The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Metronidazole in the Treatment of Alcoholism: A Negative Report

Published Online:https://doi.org/10.1176/ajp.123.10.1276

The present study was an attempt to confirm Taylor's observations that metronidazole reduces the desire of alcoholics to drink and produces disulfiram-like reactions to alcohol. Neither observation was confirmed.

Of 12 "good prognosis" alcoholics receiving metronidazole as outpatients, eight resumed heavy drinking within six weeks. Two of the remaining four patients stopped the drug because of apparent side effects and the other two, although abstinent on the drug for four months, remained sober on placebo and were unable to distinguish drug from placebo.

Disulfiram-like reactions, when reported, were equivocal and in one patient persisted on placebo.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.